M. Scot Roberts
2021
In 2021, M. Scot Roberts earned a total compensation of $2.2M as Chief Scientific Officer at PharmAthene, a 253% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $154,280 |
|---|---|
| Option Awards | $1,237,015 |
| Salary | $406,000 |
| Stock Awards | $412,135 |
| Other | $4,594 |
| Total | $2,214,024 |
Roberts received $1.2M in option awards, accounting for 56% of the total pay in 2021.
Roberts also received $154.3K in non-equity incentive plan, $406K in salary, $412.1K in stock awards and $4.6K in other compensation.
Rankings
In 2021, M. Scot Roberts' compensation ranked 5,660th out of 12,415 executives tracked by ExecPay. In other words, Roberts earned more than 54.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,660 out of 12,415 | 54th |
Division Manufacturing | 2,398 out of 5,505 | 56th |
Major group Chemicals And Allied Products | 1,043 out of 2,375 | 56th |
Industry group Drugs | 931 out of 2,096 | 56th |
Industry Pharmaceutical Preparations | 670 out of 1,546 | 57th |
Source: SEC filing on August 16, 2022.
Roberts' colleagues
We found four more compensation records of executives who worked with M. Scot Roberts at PharmAthene in 2021.